
Sign up to save your podcasts
Or


ASGCT Board of Directors member Lindsey George, MD, (Children's Hospital of Philadelphia) discusses the dramatic advancements in available treatment options for patients with hemophilia and the responsibility of scientists and clinicians in guiding patients through these once-in-a-lifetime decisions.
Host: Lynnea Olivarez, incoming chair of the ASGCT Communications Committee
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.
By American Society of Gene & Cell Therapy4.9
1616 ratings
ASGCT Board of Directors member Lindsey George, MD, (Children's Hospital of Philadelphia) discusses the dramatic advancements in available treatment options for patients with hemophilia and the responsibility of scientists and clinicians in guiding patients through these once-in-a-lifetime decisions.
Host: Lynnea Olivarez, incoming chair of the ASGCT Communications Committee
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.

21,957 Listeners

25,874 Listeners

2,057 Listeners

499 Listeners

763 Listeners

820 Listeners

6,379 Listeners

277 Listeners

9,529 Listeners

324 Listeners

6,424 Listeners

34 Listeners

16,095 Listeners

19 Listeners

39 Listeners